• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.71% Nasdaq Down 0.63%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    0.39 Down 0.01(1.28%) Sep 23, 4:00PM EDT
    Prev Close:0.39
    Open:0.40
    Bid:0.38 x 200
    Ask:0.39 x 200
    1y Target Est:1.92
    Beta:0.426822
    Earnings Date:Nov 3 - Nov 7 (Est.)
    Day's Range:0.38 - 0.41
    52wk Range:0.25 - 1.75
    Volume:401,610
    Avg Vol (3m):1,364,130
    Market Cap:108.89M
    P/E (ttm):N/A
    EPS (ttm):-0.32
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTICDown 1.28%108.89M
    BMYUp 0.11%94.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.19
    Quarterly EPS Est (Sep-16) :-0.07
    Mean Recommendation*:3.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback